2024 Q2 Form 10-Q Financial Statement
#000186872624000029 Filed on May 02, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| Revenue | $103.9M | $98.91M |
| YoY Change | -4.85% | -13.08% |
| Cost Of Revenue | $31.51M | $27.56M |
| YoY Change | -0.75% | -16.42% |
| Gross Profit | $72.44M | $71.34M |
| YoY Change | -6.53% | -11.72% |
| Gross Profit Margin | 69.69% | 72.13% |
| Selling, General & Admin | $45.42M | $40.44M |
| YoY Change | -6.18% | 15.79% |
| % of Gross Profit | 62.71% | 56.68% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $13.17M | $149.0K |
| YoY Change | 27.6% | 28.45% |
| % of Gross Profit | 18.19% | 0.21% |
| Operating Expenses | $56.16M | $51.73M |
| YoY Change | -4.39% | 14.32% |
| Operating Profit | $16.28M | $19.62M |
| YoY Change | -13.23% | -44.84% |
| Interest Expense | -$8.335M | $14.50M |
| YoY Change | -18.33% | 37.57% |
| % of Operating Profit | -51.2% | 73.94% |
| Other Income/Expense, Net | -$264.0K | -$947.0K |
| YoY Change | -56.0% | -491.32% |
| Pretax Income | $7.679M | $10.37M |
| YoY Change | -3.45% | -58.95% |
| Income Tax | $1.900M | $2.623M |
| % Of Pretax Income | 24.74% | 25.3% |
| Net Earnings | $5.779M | $7.746M |
| YoY Change | -6.12% | -63.05% |
| Net Earnings / Revenue | 5.56% | 7.83% |
| Basic Earnings Per Share | $0.01 | $0.01 |
| Diluted Earnings Per Share | $0.01 | $0.01 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 661.8M shares | 660.8M shares |
| Diluted Shares Outstanding | 663.5M shares | 663.6M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $507.9M | $507.5M |
| YoY Change | 34.22% | 37.41% |
| Cash & Equivalents | $507.9M | $507.5M |
| Short-Term Investments | ||
| Other Short-Term Assets | $12.39M | $11.54M |
| YoY Change | -7.5% | -30.75% |
| Inventory | $100.2M | $94.64M |
| Prepaid Expenses | ||
| Receivables | $33.98M | $25.81M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $654.5M | $639.5M |
| YoY Change | 14.69% | 13.48% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.225M | $1.241M |
| YoY Change | 31.44% | 20.96% |
| Goodwill | $168.3M | $168.3M |
| YoY Change | 0.0% | 0.0% |
| Intangibles | $923.4M | $935.9M |
| YoY Change | -4.97% | -4.79% |
| Long-Term Investments | $9.365M | $8.416M |
| YoY Change | ||
| Other Assets | $9.365M | $8.416M |
| YoY Change | -17.52% | -15.87% |
| Total Long-Term Assets | $1.102B | $1.114B |
| YoY Change | -4.34% | -4.17% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $654.5M | $639.5M |
| Total Long-Term Assets | $1.102B | $1.114B |
| Total Assets | $1.757B | $1.753B |
| YoY Change | 1.96% | 1.6% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $23.02M | $17.22M |
| YoY Change | 68.45% | 83.06% |
| Accrued Expenses | $22.51M | $18.16M |
| YoY Change | -8.7% | -8.85% |
| Deferred Revenue | $1.125M | $1.067M |
| YoY Change | -45.84% | -52.15% |
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $6.750M | $6.750M |
| YoY Change | 0.0% | 0.0% |
| Total Short-Term Liabilities | $70.62M | $59.73M |
| YoY Change | 15.3% | 2.57% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $646.4M | $647.7M |
| YoY Change | -0.81% | -0.81% |
| Other Long-Term Liabilities | $1.932M | $2.065M |
| YoY Change | -98.98% | -99.0% |
| Total Long-Term Liabilities | $648.3M | $649.8M |
| YoY Change | -22.92% | -0.5% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $70.62M | $59.73M |
| Total Long-Term Liabilities | $648.3M | $649.8M |
| Total Liabilities | $893.4M | $897.7M |
| YoY Change | -1.28% | -2.34% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | $540.0M | $534.2M |
| YoY Change | 9.75% | 9.96% |
| Common Stock | $676.0K | $675.0K |
| YoY Change | 3.36% | 3.37% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $863.3M | $855.7M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $1.757B | $1.753B |
| YoY Change | 1.96% | 1.6% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $5.779M | $7.746M |
| YoY Change | -6.12% | -63.05% |
| Depreciation, Depletion And Amortization | $13.17M | $149.0K |
| YoY Change | 27.6% | 28.45% |
| Cash From Operating Activities | $16.24M | $43.71M |
| YoY Change | -39.84% | -9.11% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $1.094M | $451.0K |
| YoY Change | -19.85% | 321.5% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$1.084M | |
| YoY Change | ||
| Cash From Investing Activities | -$1.094M | -$1.084M |
| YoY Change | -19.85% | 71.79% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -14.73M | -$1.517M |
| YoY Change | -11.03% | 63.82% |
| NET CHANGE | ||
| Cash From Operating Activities | 16.24M | $43.71M |
| Cash From Investing Activities | -1.094M | -$1.084M |
| Cash From Financing Activities | -14.73M | -$1.517M |
| Net Change In Cash | 419.0K | $41.11M |
| YoY Change | -95.38% | -11.66% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $16.24M | $43.71M |
| Capital Expenditures | $1.094M | $451.0K |
| Free Cash Flow | $15.15M | $43.26M |
| YoY Change | -40.9% | -9.85% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
27563000 | usd |
| CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
80810000 | usd |
| CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
2187000 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
1742000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7746000 | usd |
| CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2024Q1 | us-gaap |
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
|
25376000 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
|
31235000 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
32977000 | usd |
| CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
71343000 | usd |
| CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
40437000 | usd |
| CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
34924000 | usd |
| CY2024Q1 | olpx |
Amortization Of Other Intangible Assets
AmortizationOfOtherIntangibleAssets
|
11289000 | usd |
| CY2023Q1 | olpx |
Amortization Of Other Intangible Assets
AmortizationOfOtherIntangibleAssets
|
10323000 | usd |
| CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
51726000 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
45247000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
19617000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
35563000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
14504000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
13918000 | usd |
| CY2024Q1 | us-gaap |
Interest Income Operating
InterestIncomeOperating
|
6203000 | usd |
| CY2023Q1 | us-gaap |
Interest Income Operating
InterestIncomeOperating
|
3375000 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-947000 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
242000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
10369000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
25262000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2623000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4298000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7746000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
20964000 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
660821930 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
651730993 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
663565291 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
683485182 | shares |
| CY2024Q1 | us-gaap |
Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
|
-361000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
|
-557000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-361000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-557000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
7385000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
20407000 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
844968000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7746000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
175000 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3183000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
|
-361000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
855711000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
780957000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
20964000 | usd |
| CY2023Q1 | olpx |
Stock Issued During Period Value Non Option Equity Instruments Exercised
StockIssuedDuringPeriodValueNonOptionEquityInstrumentsExercised
|
326000 | usd |
| CY2023Q1 | olpx |
Share Based Payment Arrangement Shares Withheld For Tax Withholding Obligation Amount
ShareBasedPaymentArrangementSharesWithheldForTaxWithholdingObligationAmount
|
390000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3299000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2018000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
|
-557000 | usd |
| CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
2187000 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
1742000 | usd |
| CY2024Q1 | olpx |
Amortization Of Other Intangible Assets
AmortizationOfOtherIntangibleAssets
|
11289000 | usd |
| CY2023Q1 | olpx |
Amortization Of Other Intangible Assets
AmortizationOfOtherIntangibleAssets
|
10323000 | usd |
| CY2024Q1 | olpx |
Inventory Write Down And Disposal
InventoryWriteDownAndDisposal
|
863000 | usd |
| CY2023Q1 | olpx |
Inventory Write Down And Disposal
InventoryWriteDownAndDisposal
|
2610000 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
149000 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
116000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
453000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
453000 | usd |
| CY2024Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-231000 | usd |
| CY2023Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
847000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3183000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2018000 | usd |
| CY2024Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-265000 | usd |
| CY2023Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-265000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-15114000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-704000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-552000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-10407000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-1507000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
7108000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
9553000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-340000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-6929000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
5116000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
1994000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
28000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
43707000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
48089000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
451000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
107000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Software
PaymentsToAcquireSoftware
|
633000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Software
PaymentsToAcquireSoftware
|
524000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1084000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-631000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
171000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2513000 | usd |
| CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | usd |
| CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
64000 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
1688000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
3375000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1517000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-926000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
41106000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
46532000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
935917000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
466400000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
322808000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
507506000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
369340000 | usd |
| CY2024Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
4998000 | usd |
| CY2023Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
91000 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
14990000 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
13853000 | usd |
| CY2024Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
742000 | usd |
| CY2023Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
| CY2024Q1 | olpx |
Transfer To Due To Related Parties
TransferToDueToRelatedParties
|
587000 | usd |
| CY2023Q1 | olpx |
Transfer To Due To Related Parties
TransferToDueToRelatedParties
|
0 | usd |
| CY2024Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
9000 | usd |
| CY2023Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | usd |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Examples of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, variable consideration, and other obligations such as product returns, allowance for promotions, and refunds; loss contingencies; the fair value of share-based options and stock settled stock appreciation rights (“SARs”); the fair value of and/or potential impairment of goodwill and intangible assets for the Company’s reporting unit; the fair value of the Company’s interest rate cap; useful lives of the Company’s tangible and intangible assets; estimated income tax expense and tax payments; future payment obligations under the Tax Receivable Agreement; the net realizable value of, and demand for the Company’s inventory. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.</span></div> | |
| CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
168300000 | usd |
| CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
168300000 | usd |
| CY2024Q1 | olpx |
Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
|
1317227000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
213010000 | usd |
| CY2024Q1 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
1104217000 | usd |
| CY2021Q4 | olpx |
Tax Receivable Agreement Percent Of Tax Benefits With Provided Payment
TaxReceivableAgreementPercentOfTaxBenefitsWithProvidedPayment
|
0.85 | |
| CY2021Q4 | olpx |
Tax Receivable Agreement Percent Of Tax Benefits Retained By Company
TaxReceivableAgreementPercentOfTaxBenefitsRetainedByCompany
|
0.15 | |
| CY2024Q1 | olpx |
Tax Receivable Agreement
TaxReceivableAgreement
|
198200000 | usd |
| CY2024Q1 | olpx |
Related Party Transaction Term Of Agreement
RelatedPartyTransactionTermOfAgreement
|
P11Y | |
| CY2024Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented have been reclassified within the “Condensed Consolidated Statements of Operations and Comprehensive Income” to conform with the current period presentation, including a prior year reclassification from Interest expense, net to Interest income for three months ended March 31, 2023. The reclassifications occurred as a result of an increase in the significance of the current year amount. There was no change to the Condensed Consolidated Balance Sheet, Statements of Operations and Comprehensive Income, and Statements of Cash Flows from the reclassification.</span></div> | |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1147160000 | usd |
| CY2024Q1 | olpx |
Number Of Business Channels
NumberOfBusinessChannels
|
3 | business_channel |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
98906000 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
113787000 | usd |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
98906000 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
113787000 | usd |
| CY2024Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
30044000 | usd |
| CY2023Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
30306000 | usd |
| CY2024Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
64599000 | usd |
| CY2023Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
65616000 | usd |
| CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
94643000 | usd |
| CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
95922000 | usd |
| CY2024Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
900000 | usd |
| CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
2600000 | usd |
| CY2023 | olpx |
Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag
DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
|
Interest rate cap at December 31, 2023 | |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1148927000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
213010000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
199446000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
947714000 | usd |
| CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
168300000 | usd |
| CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
168300000 | usd |
| CY2023Q4 | olpx |
Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
|
1315460000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
199446000 | usd |
| CY2023Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
1116014000 | usd |
| CY2024Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
4102000 | usd |
| CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
4133000 | usd |
| CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4162000 | usd |
| CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4639000 | usd |
| CY2024Q1 | olpx |
Accrued Freight Current
AccruedFreightCurrent
|
1128000 | usd |
| CY2023Q4 | olpx |
Accrued Freight Current
AccruedFreightCurrent
|
1229000 | usd |
| CY2024Q1 | us-gaap |
Accrued Advertising Current And Noncurrent
AccruedAdvertisingCurrentAndNoncurrent
|
3323000 | usd |
| CY2023Q4 | us-gaap |
Accrued Advertising Current And Noncurrent
AccruedAdvertisingCurrentAndNoncurrent
|
6348000 | usd |
| CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1067000 | usd |
| CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1051000 | usd |
| CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
588000 | usd |
| CY2023Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
431000 | usd |
| CY2024Q1 | olpx |
Accrued Inventory Purchases
AccruedInventoryPurchases
|
640000 | usd |
| CY2023Q4 | olpx |
Accrued Inventory Purchases
AccruedInventoryPurchases
|
0 | usd |
| CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3146000 | usd |
| CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2745000 | usd |
| CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
18156000 | usd |
| CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
20576000 | usd |
| CY2024Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
7055000 | usd |
| CY2023Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
7415000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
654445000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
655773000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
6750000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
6750000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
647695000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
649023000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
8300000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
10500000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
654400000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
613500000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
655800000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
615100000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
551742 | shares |
| CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
225566 | shares |
| CY2023Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
3659267 | shares |
| CY2024Q1 | us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
CONTINGENCIES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is subject to various legal actions arising in the ordinary course of business. The Company cannot predict with reasonable assurance the outcome of these legal actions brought against the Company as they are subject to uncertainties. Accordingly, any settlement or resolution in these legal actions may occur and affect the Company’s net income in such period as the settlement or resolution.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending Legal Proceedings: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2022, a putative securities class action was filed against the Company and certain of its current and former officers and directors in the United States District Court for the Central District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien v. Olaplex Holdings, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-08395. A consolidated complaint was filed on April 28, 2023, which names as additional defendants the underwriters for the Company’s IPO and various stockholders that sold shares of common stock of the Company in the IPO. The action is brought on behalf of a putative class of purchasers of the Company’s common stock in or traceable to the Company’s IPO and asserts claims under Sections 11, 12, and 15 of the Securities Act of 1933. The action seeks certification of the putative class, compensatory damages, attorneys’ fees and costs, and any other relief that the court determines is appropriate. The defendants moved to dismiss the consolidated complaint on July 19, 2023. The court held a hearing on the defendants’ motions to dismiss on October 16, 2023, and a decision has yet to be issued. The underwriter defendants have notified the Company of their intent to seek indemnification from the Company pursuant to the IPO underwriting agreement regarding the claims asserted in this action. The Company intends to vigorously defend the pending lawsuit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2023, a purported derivative action was filed against the Company, Advent International Corporation, and certain of the Company’s current and former officers and directors in the United States District Court for the Central District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ciuffo v. Dagousset, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 2:23-cv-09712-SVW-SK. This action is premised on allegations similar to those asserted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> federal securities litigation. On February 1, 2024, the parties filed a joint stipulation to stay the purported derivative action pending a decision on the motions to dismiss filed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities action. </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 22, 2024, a second purported derivative action was filed against the Company, Advent International Corporation, and certain of the Company’s current and former officers and directors in the United States District Court for the Central District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hutchinson v. Advent International Corporation, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 2:24-cv-02364. This action is premised on allegations similar to those asserted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> federal securities litigation and in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ciuffo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> federal derivative action. On April 19, 2024, the parties in both purported derivative actions filed a joint stipulation to consolidate the two derivative actions and to stay proceedings in the consolidated case.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2023, twenty-eight plaintiffs filed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Albahae, et al. v. Olaplex Holdings, Inc., et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No. 2:23-cv-00982, a complaint alleging personal and economic injury and asserting claims for breach of warranty, negligence/gross negligence, products liability, unjust enrichment, and violations of California False Advertising Law and Unfair Competition Law, against the Company and Cosway Company, Inc., the Company’s primary contract manufacturer, in the United States District Court for the Central District of California. On March 2, 2023, the plaintiffs amended the complaint to include seventy-three additional plaintiffs. The plaintiffs allege that certain ingredients used in some Company products have purportedly caused irritation or posed a hazard to consumers, and that the Company engaged in misrepresentation with respect to those products. The plaintiffs seek actual and consequential damages, punitive damages, restitution in the form of disgorgement of profits, attorneys’ fees and costs, and any other relief that the court determines is appropriate. On April 17, 2023, the Company moved to dismiss and to sever the plaintiffs’ claims. On July 11, 2023, the Court granted the Company’s motion to sever and dismissed all but the first named plaintiff. The Court also dismissed the operative complaint with leave to re-file on the grounds that it now contained allegations that were not relevant to the claims of the one, remaining plaintiff. On July 24, 2023, the remaining plaintiff filed a notice, voluntarily dismissing her claims without prejudice. As of the date of issuance of these condensed consolidated financial statements, none of the plaintiffs have re-filed their claims. </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any potential loss associated with these pending legal proceedings is not probable or reasonably estimable at this time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, the Company was not subject to any other currently pending legal matters or claims that could have a material adverse effect on its financial position, results of operations, or cash flows should such litigation be resolved unfavorably.</span></div> | |
| CY2023Q1 | us-gaap |
Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
|
28 | plaintiff |
| CY2023Q1 | us-gaap |
Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
|
73 | plaintiff |
| CY2023Q3 | us-gaap |
Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
|
1 | plaintiff |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7746000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
20964000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
660821930 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
651730993 | shares |
| CY2024Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
2743361 | shares |
| CY2023Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
31754189 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
663565291 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
683485182 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
| CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8455797 | shares |
| CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1430590 | shares |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
| CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false |
